Antitumor activity of acidic mannan fraction from bakers yeast

36Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The acidic fraction of bakers’ yeast mannan containing mannose (93.6%), nitrogen (1.0%), and phosphorus (0.6%), designated as WAM025, showed a marked antitumor activity against the ascites forms of Ehrlich, sarcoma 180 and Meth A tumors in vivo. Namely, a 100% survival of mice transplanted with Ehrlich or sarcoma 180 ascites tumor, 1 X 105 cells/ddY strain mouse, was obtained by the intraperitoneal administration of WAM025, 150 mg/kg/d for 10 d. This effect evoked by WAM025 seems to be attributed to the activation of peritoneal adherent cells in mice, because a significant elevation of lysosomal enzyme level and active oxygen generation was observed on the peritoneal adherent cells obtained from the mannan-administered mice. © 1983, The Pharmaceutical Society of Japan. All rights reserved.

Cite

CITATION STYLE

APA

Suzuki, S., Okawa, Y., Suzuki, K., Okura, Y., & Suzuki, M. (1983). Antitumor activity of acidic mannan fraction from bakers yeast. Journal of Pharmacobio-Dynamics, 6(9), 668–676. https://doi.org/10.1248/bpb1978.6.668

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free